Role of Gut Microbiota in Pulmonary Arterial Hypertension

Gut microbiota and its metabolites play an important role in maintaining host homeostasis. Pulmonary arterial hypertension (PAH) is a malignant clinical syndrome with a frightening mortality. Pulmonary vascular remodeling is an important feature of PAH, and its pathogenesis is not well established....

Full description

Bibliographic Details
Published in:	Frontiers in Cellular and Infection Microbiology
Main Authors:	Panyun Wu, Tengteng Zhu, Zhen Tan, Shenglan Chen, Zhenfei Fang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Subjects:	gut dysbiosis pulmonary arterial hypertension vascular remodeling inflammation treatment
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2022.812303/full

Similar Items

Perivascular Inflammation in Pulmonary Arterial Hypertension
by: Yijie Hu, et al.
Published: (2020-10-01)

Inflammatory cells and vascular remodeling in pulmonary arterial hypertension
by: QIAN Xifeng, HUA Lu
Published: (2024-08-01)

Pulmonary Hypertension and the Gut Microbiome
by: Thomas Mason, et al.
Published: (2024-01-01)

Gut Microbiome in Pulmonary Arterial Hypertension—An Emerging Frontier
by: Sasha Z. Prisco, et al.
Published: (2025-06-01)

The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension
by: Shalina Taylor, et al.
Published: (2018-08-01)

Effect of overexpression of microRNA-124 on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Zhu Jian, Chen Tiantian, Liu Zhiyong, Zheng Changlong
Published: (2023-08-01)

The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Ting Wang, et al.
Published: (2022-02-01)

Role of macrophages in pulmonary arterial hypertension
by: Meng-Qi Zhang, et al.
Published: (2023-04-01)

Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan
by: Yumiko Ikubo, et al.
Published: (2022-04-01)

Can Sirtuin 1 Serve as a Therapeutic Target in Pulmonary Arterial Hypertension? A Comprehensive Review
by: Sandra Budziak, et al.
Published: (2025-09-01)

RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension
by: Lu G, et al.
Published: (2023-10-01)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
by: Rubin Tan, et al.
Published: (2022-11-01)

Novel Insights Into Receptor Tyrosine Kinases in Pulmonary Arterial Hypertension
by: Wenze Wu, et al.
Published: (2025-08-01)

Emerging Mechanistic Insights and Therapeutic Strategies for Pulmonary Arterial Hypertension: A Focus on Right Ventricular Dysfunction and Novel Treatment Pathways
by: Masab Mansoor, et al.
Published: (2025-03-01)

Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
by: Yusheng Cheng, et al.
Published: (2018-08-01)

Gut microbiota and atrial cardiomyopathy
by: Tingting Sun, et al.
Published: (2025-02-01)

Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling
by: Xiaowei Nie, et al.
Published: (2021-11-01)

Arterial remodeling in older patients with arterial hypertension
by: A. V. Agafonov, et al.
Published: (2005-06-01)

Pulmonary Arterial Hypertension: Iron Matters
by: Latha Ramakrishnan, et al.
Published: (2018-05-01)

The effect of rehabilitation exercise on the expression of glutaminase and cardiopulmonary remodeling in pulmonary hypertension
by: Shang Wang, et al.
Published: (2022-09-01)

TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
by: Shi Haixia, et al.
Published: (2023-07-01)

Optimization of resting tension for wire myography in male rat pulmonary arteries
by: Rira Choi, et al.
Published: (2024-01-01)

The role and mechanism of thrombospondin-4 in pulmonary arterial hypertension associated with congenital heart disease
by: Haowei Zeng, et al.
Published: (2024-08-01)

Hydrogen Sulfide Metabolism and Pulmonary Hypertension
by: Lukas Roubenne, et al.
Published: (2021-06-01)

Glutaminolysis: A Driver of Vascular and Cardiac Remodeling in Pulmonary Arterial Hypertension
by: Richard Mprah, et al.
Published: (2021-04-01)

Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study
by: Ye Yuan, et al.
Published: (2024-05-01)

HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape
by: Sandra Medrano-Garcia, et al.
Published: (2022-08-01)

Metabolic alterations in human pulmonary artery smooth muscle cells treated with PDGF‐BB
by: Meng‐Jie Zhang, et al.
Published: (2025-07-01)

Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension
by: Yun Han, et al.
Published: (2021-07-01)

The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?
by: Julien Solinc, et al.
Published: (2022-04-01)

Recent trends in pulmonary arterial hypertension
by: Rajagopalan Natarajan
Published: (2011-01-01)

Perillyl alcohol suppresses monocrotaline-induced pulmonary arterial hypertension in rats via anti-remodeling, anti-oxidant, and anti-inflammatory effects
by: Ahmad Beik, et al.
Published: (2021-04-01)

THBS1 mediates hypoxia driven EndMT in pulmonary hypertension
by: Bingming Peng, et al.
Published: (2024-10-01)

Pulmonary arterial hypertension in the elderly: Clinical perspectives
by: Nicholas Rothbard, et al.
Published: (2020-05-01)

The causal effect of gut microbiome on pulmonary artery hypertension based on a two-sample Mendelian randomization study
by: Detian Jiang, et al.
Published: (2025-07-01)

Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models
by: Huayang Li, et al.
Published: (2021-11-01)

Features of clinical-functional parameters of the heart, vessels and microcirculation in patients with arterial hypertension in the combination to chronic obstructive pulmonary diseases
by: I. S. Shpagin, et al.
Published: (2010-12-01)

Implications of Hydrogen Sulfide in Development of Pulmonary Hypertension
by: Yan Sun, et al.
Published: (2022-06-01)

Gut microbiota in hypertensive patients with versus without obstructive sleep apnea
by: Dasheng Lu, et al.
Published: (2022-12-01)

vASCULAR AND CARDIAC REMODELLING AND COMbINATION THERAPY OF ARTERIAL HYPERTENSION IN PATIENTS WITH CHRONIC ObSTRUCTIvE PULMONARY DISEASE
by: L. A. Shpagina, et al.
Published: (2014-01-01)